
Cancer Immunotherapy
On this page
Get care
Why choose UCSF Health for immunotherapy treatment?
Immunotherapies (drugs that harness the immune system to fight diseases) are among the newest treatments available for certain types of cancer. Researchers and physicians at UCSF Health are at the forefront of this field, studying and testing the newest and most promising immune-based medicines for cancer and other diseases.
Many of our research initiatives are funded by the National Cancer Institute (NCI) and bring together the nation's top immunotherapy cancer researchers and clinicians.
Why choose UCSF Health for immunotherapy treatment?
Immunotherapies (drugs that harness the immune system to fight diseases) are among the newest treatments available for certain types of cancer. Researchers and physicians at UCSF Health are at the forefront of this field, studying and testing the newest and most promising immune-based medicines for cancer and other diseases.
Many of our research initiatives are funded by the National Cancer Institute (NCI) and bring together the nation's top immunotherapy cancer researchers and clinicians.
Get care
First in California
UCSF Health was the first in the state to offer CAR T-cell therapy for young adults and children with acute lymphoblastic leukemia, an aggressive blood cancer.Team approach
Medical oncologists, hematologists, pathologists and specialized nurses work together to select the right therapies for your needs.Clinical trials
We are leading clinical trials to test better treatments, such as a new, more targeted immunotherapy for aggressive brain cancer developed at UCSF Health.Leaders in immunotherapy research
We are part of the UCSF Cancer Immunotherapy Program, studying immune-based therapies for cancer and translating our discoveries into better patient care.
Our approach to immunotherapy for cancer care
Immunotherapies stimulate your immune system to better identify and destroy cancer cells. We may recommend immunotherapy for advanced cancer or cancer that hasn't responded to standard treatments. Immunotherapy can be used to treat many cancer types, including breast, pelvic, blood, brain and lung cancers.
Immunotherapy is tailored to each person's biology, tumor type and immune system response, making it a highly precise treatment that can have fewer side effects than chemotherapy or radiation therapy.
Types of immunotherapy
Medical oncologists at UCSF Health evaluate your medical history and type of tumor to find out if immunotherapy may be right for you.
Types of immunotherapy we offer include:
Cancer vaccines. Cancer cells or proteins from cancer cells are used to trigger your immune system to respond against cancer.
Cell therapy. Different types of immune cells are modified to fight cancer. CAR T cells (gene-modified, cancer-fighting cells) are one example of this.
Checkpoint inhibitors. These drugs disable the "off switch" on immune cells, allowing them to better attack cancer cells.
Immune system modulators. Certain medications boost your immune system to prevent cancer cells from growing and dividing.
Monoclonal antibodies. Synthetic proteins made in a lab are designed to target specific molecules on cancer cells.
Providers

Kelly Fitzgerald, MD
Genitourinary Medical Oncology

Thomas G. Martin III, MD
Hematology Oncology • Myeloma
David Oh, MD, PhD
Urologic Oncology
Excellence in patient care

Best in California and No. 7 in the nation for cancer care
Related conditions & treatments
Treatments
- Cancer Immunotherapy
- Chimeric Antigen Receptor T-Cell Therapy
- Clinical Trials
Explore what we do

Cancer Immunotherapy Toxicity Evaluation
We offer specialized evaluations and care for people with immunotherapy side effects. Our program is among the first of its kind in the country.
Clinical trials
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple MyelomaOpens in a new window
Safety will be evaluated for the population of participants who received at least one dose of study drug. Treatment-emergent AEs will be graded by the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.
Accreditations & memberships

National Cancer Institute
The National Cancer Institute has designated UCSF Health a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
Commission on Cancer
UCSF Health's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
National Comprehensive Cancer Network
UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world's top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.










